193 related articles for article (PubMed ID: 22068367)
1. Successful treatment of toxic epidermal necrolysis/Stevens-Johnson syndrome overlap with human granulocyte colony stimulating factor: a case report.
Pallesen KA; Robinson S; Toft P; Andersen KE
Acta Derm Venereol; 2012 Mar; 92(2):212-3. PubMed ID: 22068367
[No Abstract] [Full Text] [Related]
2. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
[TBL] [Abstract][Full Text] [Related]
3. Hematological abnormalities and the use of granulocyte-colony-stimulating factor in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Ang CC; Tay YK
Int J Dermatol; 2011 Dec; 50(12):1570-8. PubMed ID: 22098009
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
Ririe MR; Blaylock RC; Morris SE; Jung JY
J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
[TBL] [Abstract][Full Text] [Related]
5. Stevens-Johnson syndrome and toxic epidermal necrolysis overlap in a patient receiving cetuximab and radiotherapy for head and neck cancer.
Urosevic-Maiwald M; Harr T; French LE; Dummer R
Int J Dermatol; 2012 Jul; 51(7):864-7. PubMed ID: 22715836
[TBL] [Abstract][Full Text] [Related]
6. [Use of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis and Stevens-Johnson/toxic epidermal necrolysis overlap syndrome. Review of 15 cases].
Molgó M; Carreño N; Hoyos-Bachiloglu R; Andresen M; González S
Rev Med Chil; 2009 Mar; 137(3):383-9. PubMed ID: 19621180
[TBL] [Abstract][Full Text] [Related]
7. Use of granulocyte colony-stimulating factor in the treatment of toxic epidermal necrolysis--experience with 3 patients.
Mahajan R; Kanwar AJ
Skinmed; 2013; 11(5):269-71. PubMed ID: 24340465
[TBL] [Abstract][Full Text] [Related]
8. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
[TBL] [Abstract][Full Text] [Related]
9. Pentoxyfylline in toxic epidermal necrolysis and Stevens-Johnson syndrome.
Sanclemente G; De la Roche CA; Escobar CE; Falabella R
Int J Dermatol; 1999 Nov; 38(11):878-9. PubMed ID: 10583942
[No Abstract] [Full Text] [Related]
10. Outcome of Stevens Johnson syndrome and toxic epidermal necrolysis treated with corticosteroids.
Rijal A; Agrawal S
Indian J Dermatol Venereol Leprol; 2009; 75(6):613-4. PubMed ID: 19915248
[No Abstract] [Full Text] [Related]
11. Case report: psychosis with Stevens-Johnson syndrome and toxic epidermal necrolysis.
de Rego JA; Goldstein DM
Hillside J Clin Psychiatry; 1985; 7(2):141-8. PubMed ID: 4077031
[TBL] [Abstract][Full Text] [Related]
12. Systemic and local management at the onset of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.
Sotozono C; Ueta M; Kinoshita S
Am J Ophthalmol; 2010 Feb; 149(2):354; author reply 355. PubMed ID: 20103059
[No Abstract] [Full Text] [Related]
13. IVIG for the treatment of toxic epidermal necrolysis.
Mittmann N; Chan BC; Knowles S; Shear NH
Skin Therapy Lett; 2007 Feb; 12(1):7-9. PubMed ID: 17361314
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced Lyell and Stevens-Johnson syndromes.
Prescrire Int; 2009 Feb; 18(99):20-2. PubMed ID: 19391288
[TBL] [Abstract][Full Text] [Related]
15. [Considerations on a case of toxic epidermic necrolysis (Lyell's syndrome) with Stevens-Johnson pluriorificial syndrome].
Cislaghi F; Pagliano Sassi L; Moreno A
Minerva Pediatr; 1967 Mar; 19(12):540-2. PubMed ID: 5607236
[No Abstract] [Full Text] [Related]
16. Early gynaecological assessment following Stevens-Johnson syndrome/toxic epidermal necrolysis.
Madhuri TK; Kremer C
J Obstet Gynaecol; 2010; 30(8):871-2. PubMed ID: 21126137
[No Abstract] [Full Text] [Related]
17. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
Tan SK; Tay YK
Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108
[TBL] [Abstract][Full Text] [Related]
18. The management of severe ocular complications of stevens-johnson syndrome and toxic epidermal necrolysis.
Sotozono C; Ueta M; Kinoshita S
Arch Dermatol; 2009 Nov; 145(11):1336-7; author reply 1337-8. PubMed ID: 19917974
[No Abstract] [Full Text] [Related]
19. Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with the acquired immunodeficiency syndrome in Germany.
Rzany B; Mockenhaupt M; Stocker U; Hamouda O; Schöpf E
Arch Dermatol; 1993 Aug; 129(8):1059. PubMed ID: 8352614
[No Abstract] [Full Text] [Related]
20. Stevens-Johnson syndrome and toxic epidermal necrolysis: efficacy of intravenous immunoglobulin and a review of treatment options.
Teo L; Tay YK; Liu TT; Kwok C
Singapore Med J; 2009 Jan; 50(1):29-33. PubMed ID: 19224081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
